Your browser doesn't support javascript.
loading
Janus Kinase 3 (JAK3): A Critical Conserved Node in Immunity Disrupted in Immune Cell Cancer and Immunodeficiency.
Liongue, Clifford; Ratnayake, Tarindhi; Basheer, Faiza; Ward, Alister C.
Afiliación
  • Liongue C; School of Medicine, Deakin University, Geelong, VIC 3216, Australia.
  • Ratnayake T; The Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, VIC 3216, Australia.
  • Basheer F; School of Medicine, Deakin University, Geelong, VIC 3216, Australia.
  • Ward AC; School of Medicine, Deakin University, Geelong, VIC 3216, Australia.
Int J Mol Sci ; 25(5)2024 Mar 04.
Article en En | MEDLINE | ID: mdl-38474223
ABSTRACT
The Janus kinase (JAK) family is a small group of protein tyrosine kinases that represent a central component of intracellular signaling downstream from a myriad of cytokine receptors. The JAK3 family member performs a particularly important role in facilitating signal transduction for a key set of cytokine receptors that are essential for immune cell development and function. Mutations that impact JAK3 activity have been identified in a number of human diseases, including somatic gain-of-function (GOF) mutations associated with immune cell malignancies and germline loss-of-function (LOF) mutations associated with immunodeficiency. The structure, function and impacts of both GOF and LOF mutations of JAK3 are highly conserved, making animal models highly informative. This review details the biology of JAK3 and the impact of its perturbation in immune cell-related diseases, including relevant animal studies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes de Inmunodeficiencia / Neoplasias Límite: Animals / Humans Idioma: En Revista: Int J Mol Sci Año: 2024 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes de Inmunodeficiencia / Neoplasias Límite: Animals / Humans Idioma: En Revista: Int J Mol Sci Año: 2024 Tipo del documento: Article País de afiliación: Australia